Neuropeptide Y: Optimized solid‐phase synthesis and conformational analysis in trifluoroethanol

Dale F. MIERKE, Hansjörg DÜRR, Horst KESSLER, Günther JUNG

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

50 Zitate (Scopus)

Abstract

The 36‐amino‐acid neuropeptide Y (human), which is one of the most potent vasoconstrictors and which exhibits a number of other biological functions, has been synthesized using automated peptide synthesis. The optimized method, using 9‐fluorenylmethoxycarbonyl protecting and single‐step coupling, yielded the crude product in 90% purity allowing for single‐step reversed‐phase HPLC purification to >98% purity and a high overall yield (50%). The hormone was characterized by several chromatographic methods, ion‐spray mass spectroscopy and Edman degradation. The conformation of human neuropeptide Y was examined by CD, NMR and computer simulations. The CD measurements in trifluoroethanol/water (9:1) show a large percentage of α‐helix. Variation of concentration, from 0.5 μM increasing up to the 1 mM used for NMR measurements, indicates no evidence for aggregation. In the same solvent system, the NMR line widths were very broad and therefore the resonance assignment was achieved with the exclusive use of two‐dimensional NOE spectra. The 248 clearly distinguishable NOEs from the NMR study were used in distance geometry calculations and the resulting structures were refined with restrained molecular dynamics. The results indicate an α‐helix extending from Arg19 to Gln34. For the N‐terminal half of the molecule no regular structure was observed.

OriginalspracheEnglisch
Seiten (von - bis)39-48
Seitenumfang10
FachzeitschriftEuropean Journal of Biochemistry
Jahrgang206
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - Mai 1992

Fingerprint

Untersuchen Sie die Forschungsthemen von „Neuropeptide Y: Optimized solid‐phase synthesis and conformational analysis in trifluoroethanol“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren